Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enriched by the incredible
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enriched by the incredible
General Information We can currently only consider applications from candidates based in Europe or the USA. This position is remote, hybrid, or in-office, depending on the project. Regular travel to the race track is required. Your
Job Description: The Role We are seeking a Senior Performance and Attribution Consultant, who will support multiple types of investment performance reporting, attribution, and competitor analytics for a broad range of Fidelity portfolios. In this role,
About the job: Maintaining top-tier safety standards at macro scale: Allegro is a safe platform for millions of users. You will design, develop, and maintain backend systems that keep frauds and policy violations at an absolute minimum.
As part of Absolute’s rapidly growing LATAM Sales Team, the Activation Specialist engages brand new customers to activate Absolute technology and deliver “lightbulb moments” to make them customers-for-life. We will provide you with the training to become an
Absolute Security is investing heavily in net new Enterprise growth. As an Enterprise Account Executive, you will own agreenfieldterritory and be accountable for closing new logo ARR within Fortune1000 and Global2000 enterprises. You will be the tip of
As part of Absolute’s rapidly growing EMEAI Sales Team, the Activation Specialist engages brand new customers to activate Absolute technology and deliver “lightbulb moments” to make them customers-for-life. We will provide you with the training to become an
As part of Absolute’s rapidly growing LATAM Sales Team, the Activation Specialist engages brand new customers to activate Absolute technology and deliver “lightbulb moments” to make them customers-for-life. We will provide you with the training to become an
Absolute Security is the leader in enterprise resilience. We help organizations ensure their endpoints and access environments remain secure, visible, and recoverable—no matter where work happens. Our Secure Access platform delivers critical connectivity and security capabilities across distributed environments.
Work from anywhere, impact everywhere Diversity is at the heart of who we are at Xapo Bank. We’re a fully distributed team of over 160 Xapiens that work remotely from 50+ countries around the world. Our
About Us Spellman High Voltage Electronics Corporation, a family owned business for over 75 years, takes pride in powering progress in health, security and quality of life. We are key partners with the world’s leading medical devices,
About Zscaler Zscaler accelerates digital transformation to ensure our customers can be more agile, efficient, resilient, and secure. As an AI-forward enterprise, we are constantly pushing the envelope, leveraging the world’s largest security data lake to power
Absolute Security is building the #1 Agentic Cyber Resilience platform, and we need a Creative Director who can match that ambition with work that looks and feels like a market leader. This isn’t a role where you hand
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)